Furthermore, many of the cancer cell lines, including breast, colon, non-small cell lung, renal, melanoma, ovarian, and prostate cancer cell lines, have been found to express varying levels of EGFR; thus, it was worth testing their anti-EGFR activity[30,31,32,33,34,35,36]. The gene discussed is EGFR; the disease is prostate carcinoma.